These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23316034)

  • 1. Fibroblast-derived CCL2 induces cancer stem cells--letter.
    Gunaydin G; Dolen Y; Kesikli SA
    Cancer Res; 2013 Jan; 73(2):1031. PubMed ID: 23316034
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibroblast-derived CCL2 induces cancer stem cells--response.
    Tsuyada A; Wang SE
    Cancer Res; 2013 Jan; 73(2):1032-3. PubMed ID: 23316033
    [No Abstract]   [Full Text] [Related]  

  • 3. CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.
    Tsuyada A; Chow A; Wu J; Somlo G; Chu P; Loera S; Luu T; Li AX; Wu X; Ye W; Chen S; Zhou W; Yu Y; Wang YZ; Ren X; Li H; Scherle P; Kuroki Y; Wang SE
    Cancer Res; 2012 Jun; 72(11):2768-79. PubMed ID: 22472119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescent dermal fibroblasts enhance stem cell migration through CCL2/CCR2 axis.
    Ohgo S; Hasegawa S; Hasebe Y; Mizutani H; Nakata S; Akamatsu H
    Exp Dermatol; 2015 Jul; 24(7):552-4. PubMed ID: 25808810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast-dependent regulation of the stem cell properties of cancer cells.
    Weiland A; Roswall P; Hatzihristidis TC; Pietras K; Ostman A; Strell C
    Neoplasma; 2012; 59(6):719-27. PubMed ID: 22862173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of CCL2-CCR2A/2B signaling for monocyte migration into spheroids of breast cancer-derived fibroblasts.
    Ksiazkiewicz M; Gottfried E; Kreutz M; Mack M; Hofstaedter F; Kunz-Schughart LA
    Immunobiology; 2010; 215(9-10):737-47. PubMed ID: 20605053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells.
    Fang WB; Yao M; Jokar I; Alhakamy N; Berkland C; Chen J; Brantley-Sieders D; Cheng N
    Breast Cancer Res Treat; 2015 Apr; 150(2):309-20. PubMed ID: 25744294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
    Soria G; Ben-Baruch A
    Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6.
    Liu X; Das AM; Seideman J; Griswold D; Afuh CN; Kobayashi T; Abe S; Fang Q; Hashimoto M; Kim H; Wang X; Shen L; Kawasaki S; Rennard SI
    Am J Respir Cell Mol Biol; 2007 Jul; 37(1):121-8. PubMed ID: 17379849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue.
    Silzle T; Kreutz M; Dobler MA; Brockhoff G; Knuechel R; Kunz-Schughart LA
    Eur J Immunol; 2003 May; 33(5):1311-20. PubMed ID: 12731056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Breast cancer stem cells].
    Yasuda K; Hirohashi Y; Torigoe T
    Nihon Rinsho; 2012 Sep; 70 Suppl 7():76-83. PubMed ID: 23350369
    [No Abstract]   [Full Text] [Related]  

  • 13. FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling.
    Yang X; Lin Y; Shi Y; Li B; Liu W; Yin W; Dang Y; Chu Y; Fan J; He R
    Cancer Res; 2016 Jul; 76(14):4124-35. PubMed ID: 27216177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells of the mammary epithelium and their role in breast cancer.
    Vafaizadeh V; Groner B
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S174-6. PubMed ID: 23083579
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer stem cells and the cell cycle: targeting the drive behind breast cancer.
    Velasco-Velázquez MA; Yu Z; Jiao X; Pestell RG
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):275-9. PubMed ID: 19275505
    [No Abstract]   [Full Text] [Related]  

  • 16. Three-dimensional fibroblast-tumor cell interaction causes downregulation of RACK1 mRNA expression in breast cancer cells in vitro.
    Seidl P; Huettinger R; Knuechel R; Kunz-Schughart LA
    Int J Cancer; 2002 Nov; 102(2):129-36. PubMed ID: 12385007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
    Potter SM; Dwyer RM; Hartmann MC; Khan S; Boyle MP; Curran CE; Kerin MJ
    Breast Cancer Res Treat; 2012 Jan; 131(2):401-11. PubMed ID: 21344235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-induced tumor-initiating cancer stem-like cells activate stromal fibroblasts in a xenograft tumor model.
    Sasaki R; Devhare P; Ray RB; Ray R
    Hepatology; 2017 Dec; 66(6):1766-1778. PubMed ID: 28664988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of stem cell gene Oct-4 expression in breast cancer.
    Liu CG; Lu Y; Wang BB; Zhang YJ; Zhang RS; Lu Y; Chen B; Xu H; Jin F; Lu P
    Ann Surg; 2011 Jun; 253(6):1165-71. PubMed ID: 21394007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer stem cells and tumor suppressor genes.
    Hwang-Verslues WW; Chang KJ; Lee EY; Lee WH
    J Formos Med Assoc; 2008 Oct; 107(10):751-66. PubMed ID: 18926942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.